Dna X, Inc. (SONM) Stock Price & Analysis
Dna X, Inc. (SONM) fell 4.19% to USD 4.8 as of June 10, 2026 at 04:57 UTC, according to Nexqual real-time market data.
SONM last closed at USD 5.01; the session ranged USD 4.8–5.05 on volume of 9,990 shares. Market capitalization is $7.14M, with a 52-week range of USD 2.52–38.52 (NCM). Source: Nexqual, June 10, 2026 at 04:57 UTC.
Key Statistics (as of June 10, 2026 at 04:57 UTC)
| Price | USD 4.8 |
|---|---|
| Change | ▼ 4.19% (down) |
| Previous Close | USD 5.01 |
| Open | USD 4.96 |
| Day Range | USD 4.8 – 5.05 |
| 52-Week Range | USD 2.52 – 38.52 |
| Volume | 9,990 shares |
| Market Cap | $7.14M |
| Exchange | NCM |
Technical Analysis (SONM)
Nexqual's technical model rates SONM "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 04:57 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.89 (neutral) |
| vs SMA50 | Above (USD 4.25) |
| MACD | 0.12 (positive) |
Analyst Ratings (SONM)
Wall Street analysts rate SONM "None", per Nexqual as of June 10, 2026 at 04:57 UTC.
| Consensus Rating | None |
|---|
Earnings (SONM)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-09-30 | USD -9.36 vs est -11.88 ▲ beat |
| 2024-06-30 | USD -25.38 vs est -9.72 ▼ miss |
| 2024-03-31 | USD -12.6 vs est -5.4 ▼ miss |
Source: Nexqual, June 10, 2026 at 04:57 UTC.
Financials & Fundamentals (SONM)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.76 |
| Total Cash | $1.20M |
| Total Debt | $1.07M |
| Free Cash Flow | $-6.97M |
Source: Nexqual, June 10, 2026 at 04:57 UTC.
Financial Health Score (SONM)
Nexqual rates Dna X, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:57 UTC.
| Growth | Critical — Revenue -100% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $1M cash vs $1M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$17M |
| Efficiency | Mixed — No data |
Ownership (SONM)
| Insider Ownership | +37.34% |
|---|---|
| Institutional Ownership | +6.40% |
| Shares Outstanding | 1.49M |
| Float | 1.21M |
| Short % of Float | +4.46% |
Source: Nexqual, June 10, 2026 at 04:57 UTC.
Leadership (SONM)
Dna X, Inc. is led by Michael C. Mulica (age 62), Executive Chairman & Acting CEO, per Nexqual as of June 10, 2026 at 04:57 UTC.
| Executive Chairman & Acting CEO | Michael C. Mulica (age 62) |
|---|---|
| Chief Financial Officer | Clayton Crolius (age 62) |
| Senior Vice President of Global Operations | Zhide Wang |
| Senior Vice President of Sales & Customer Experience | Dyan Kaplan |
| Vice President of Marketing | Anette Gaven |
Major Backers & Investors (SONM)
Notable institutional backers of Dna X, Inc. include UBS Group AG, C2c Wealth Management, LLC , Fidelity, according to Nexqual as of June 10, 2026 at 04:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 2.43% |
| C2c Wealth Management, LLC | 1.34% |
| Fidelity | 0.99% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.99% |
| Vanguard Group | 0.96% |
| BlackRock | 0.94% |
Source: Nexqual, June 10, 2026 at 04:57 UTC.
From Dna X, Inc.'s Latest SEC 10-K Filing (filed 2026-04-15)
Key Strengths & Strategy (as disclosed to the SEC)
- We have developed customizations to standard software that we believe makes it difficult for others to duplicate our platform.
- Our platform allows users to execute strategies between pairs of cryptocurrencies that allow them to swap between the currencies as the prices diverge or converge.
- We are developing products to increase the number of cryptocurrencies that are available for trading on our platform and products the Company expects to bring in additional customers and drive additional revenue from commissions and fees.   We are currently operating on a limited basis to monitor the platform and address any bugs or performance issues.
- We may use social media and traditional media to market our platform to potential customers.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FAMI | Farmmi, Inc. Ordinary Shares | USD 1.12 | ▼ 1.75% |
| GRNQ | Greenpro Capital Corp. | USD 1.51 | ▼ 1.31% |
| SXTC | China SXT Pharmaceuticals, Inc. | USD 1.56 | ▲ 8.33% |
| DATS | DatChat, Inc. | USD 2.66 | ▲ 16.96% |
| WORX | SCWorx Corp. | USD 0.26 | ▼ 24.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:57 UTC. This page is informational and not investment advice.